Abstract
Amlodipine is a dihydropyridine calcium channel blocker that is widely used for the treatment of hypertensive patients and has an antioxidant effect on vessels in vitro. The aim of the present study was to examine whether treatment with amlodipine reduced oxidative stress in the brains of stroke-prone spontaneously hypertensive rats (SHRSP). The animals received amlodipine, nicardipine or hydralazine for 30 days in their drinking water. Levels of thiobarbituric acid-reactive substances (TBARS) in the brain (cortex, cerebellum, hypothalamus, and brainstem) were measured before and after each treatment. Systolic blood pressure decreased to similar levels in the amlodipine-, nicardipine-, and hydralazine-treated groups. Urinary norepinephrine excretion was significantly reduced in SHRSP after treatment with amlodipine, but not with nicardipine or hydralazine. Levels of TBARS in the cortex, cerebellum, hypothalamus, and brainstem were significantly higher in SHRSP than in Wistar-Kyoto rats (WKY), and were reduced in amlodipine-treated, but not in nicardipine- or hydralazine-treated, SHRSP. Electron spin resonance spectroscopy revealed increased levels of reactive oxygen species in the brains of SHRSP, which were reduced by treatment with amlodipine. Intracisternal infusion of amlodipine also reduced systolic blood pressure, urinary norepinephrine excretion, and the levels of TBARS in the brain. These results suggested that oxidative stress in the brain was enhanced in SHRSP compared with WKY rats. In addition, antihypertensive treatment with amlodipine reduced oxidative stress in all areas of the brain examined and decreased blood pressure without a reflex increase in sympathetic nerve activity in SHRSP.
Similar content being viewed by others
Article PDF
References
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–2997.
Julius S, Kjeldsen SE, Weber M, et al: Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363: 2022–2031.
Furberg CD, Psaty BM, Meyer JV : Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1325–1331.
Pahor M, Applegate WB, Williamson JD, et al: Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomized controlled trials. Lancet 2000; 356: 1949–1954.
Opie LH, Yasuf S, Küber W : Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies. Prog Cardiovasc Dis 2000; 43: 171–196.
Chen L, Haught WH, Yang B, Saldeen TG, Parathasarathy S, Mehta JL : Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol 1997; 30: 569–575.
Kataoka C, Egashira K, Ishibashi M, et al: Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis. Am J Physiol Heart Circ Physiol 2004; 286: H768–H774.
Gerzanich V, Ivanova S, van der Heijden MS, Zhou H, Simard JM : Trans-cellular proliferating cell nuclear antigen gene activation in cerebral vascular smooth muscle by endothelial oxidative injury in vivo. Arterioscler Thromb Vasc Biol 2003; 23: 2048–2054.
Blezer ELA, Nicolay K, Goldschmeding R, Koomans HA, Joles JA : Reduction of cerebral injury in stroke-prone spontaneously hypertensive rats by amlodipine. Eur J Pharmacol 2002; 444: 75–81.
Pitt B, Byington RP, Furberg CD, et al, PREVENT Investigators : Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000; 102: 1503–1510.
Zhang X, Hintze TH : Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation 1998; 97: 576–580.
Zhou M-S, Jaimes EA, Raij L : Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am J Hypertens 2004; 17: 167–171.
Mason RP, Walter MF, Trumbore MW, Olmstead EG Jr, Mason PE : Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine. J Mol Cell Cardiol 1999; 31: 275–281.
Yamagata K, Ichinose S, Tagami M : Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Hypertens Res 2004; 27: 271–282.
Binggeli C, Corti R, Sudano I, Luscher TF, Noll G : Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension. Hypertension 2002; 39: 892–896.
Fogari R, Zoppi A, Corradi L, Preti P, Malalamani GD, Mugellini A : Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. J Hypertens 2000; 18: 1871–1875.
Hamada T, Watanabe M, Kaneda T, et al: Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine. J Hypertens 1998; 16: 111–118.
Ishimitsu T, Kobayashi T, Honda T, et al: Protective effects of an angiotensin II receptor blocker and a long-acting calcium channel blocker against cardiovascular organ injuries in hypertensive patients. Hypertens Res 2005; 28: 351–359.
Soong TW, Stea A, Hodson CD, Dubel SJ, Vincent SR, Snutch TP : Structure and functional expression of a member of the low voltage-activated calcium channel family. Science 1993; 260: 1133–1136.
Miller RJ : Multiple calcium channels and neuronal function. Science 1987; 235: 46–52.
Murzenok PP, Huang BS, Leenen FHH : Sympatho-inhibition by central and peripheral infusion of nifedipine in spontaneously hypertensive rats. Hypertension 2000; 35: 631–636.
Huang BS, Leenen FHH : Sympathoinhibitory and depressor effects of amlodipine in spontaneously hypertensive rats. J Cardiovasc Pharmacol 2003; 42: 153–160.
Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A : Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109: 2357–2362.
Touyz RM : Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension. Hypertension 2004; 44: 248–252.
Ganafa AA, Walton M, Eatman D, Abukhalaf IK, Bayorh MA : Amlodipine attenuates oxidative stress-induced hypertension. Am J Hypertens 2004; 17: 743–748.
De Champlain J, Karas M, Nguyen P, et al: Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens 1998; 16: 1357–1369.
Taddei S, Virdis A, Ghiadoni L, et al: Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension 2003; 41: 950–955.
Yavuz DG, Tugler S, Koçak H, Ozener C, Akoglu E, Akalin S : Angiotensin converting enzyme inhibition and calcium channel blockage improves cyclosporine induced glucose intolerance in rats. Transplant Proc 2004; 36: 171–174.
Toblli JE, Stella I, Mazza ON, Fender L, Inserra F : Different effect of losartan and amlodipine on penile structure in male spontaneously hypertensive rats. Am J Nephrol 2004; 24: 614–623.
Toba H, Nakagawa Y, Miki S, et al: Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the NG-nitro- L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure lowering effects of amlodipine and manidipine. Hypertens Res 2005; 28: 689–700.
Kishi T, Hirooka Y, Mukai Y, Shimokawa H, Takeshita A : Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats. J Hypertens 2003; 21: 379–386.
Ide T, Tsutsui H, Kinugawa S, et al: Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 1999; 85: 357–363.
Ide T, Tsutsui H, Kinugawa S, et al: Direct evidence for increased hydroxyradicals originating from superoxide in the failing myocardium. Circ Res 2000; 86: 152–157.
Ito K, Hirooka Y, Kishi T, et al: Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition. Hypertension 2004; 43: 156–162.
Kimura Y, Hirooka Y, Sagara Y, et al: Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress. Circ Res 2005; 96: 252–260.
Sugawara H, Tobise K, Kikuchi K : Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation. Hypertens Res 1996; 19: 223–228.
Lippoldt A, Kneisel U, Liebner S, et al: Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood–brain barrier endothelial cells. Brain Res 2000; 885: 251–261.
Lu C, Chan SL, Mattson MP : The lipid peroxidation product 4-hydroxynoneal facilitates opening of voltage-dependent Ca2+ channels in neurons by increasing protein tyrosine phosphorylation. J Biol Chem 2002; 277: 24368–24375.
Tseng W-P, Lin-Shiau S-Y : Neuronal death signaling by β-bungarotoxin through the activation of the N-methyl-D-aspartate (NMDA) receptor and L-type calcium channel. Biochem Pharmacol 2003; 65: 131–142.
Wang R-M, Zhang Q-G, Zhang G-Y : Activation of ERK5 is mediated by N-methyl-D-aspartate receptor and L-type voltage-gated calcium channel via Src involving oxidative stress after cerebral ischemia in rat hippocampus. Neurosci Lett 2004; 357: 13–16.
Fukuo K, Yang J, Yasuda O, et al: Nifedipine indirectly upregulates superoxide dismutase expression in endothelial cells via vascular smooth muscle cell–dependent pathways. Circulation 2002; 106: 356–361.
Napoli C, Salomone S, Godfraind T, et al: 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats. Stroke 1999; 30: 1907–1915.
Hou X, Gobeil F, Marrache AM, et al: Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity. Am J Physiol Regul Integr Comp Physiol 2003; 284: 928–935.
Kikugawa K, Kojima T, Yamaki S, Kosugi H : Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acid. Anal Biochem 1992; 202: 249–255.
Ohtsuki T, Matsumoto M, Suzuki K, Taniguchi N, Kamada T : Mitochondrial lipid peroxidation and superoxide dismutase in rat hypertensive target organs. Am J Physiol 1995; 268: H1418–H1421.
Kishi T, Hirooka Y, Ito K, Sakai K, Shimokawa H, Takeshita A : Cardiovascular effects of overexpression of endothelial nitric oxide synthase in the rostral ventrolateral medulla in stroke-prone spontaneously hypertensive rats. Hypertension 2002; 39: 264–268.
Dampney RAL : Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74: 323–364.
Pilowsky PM, Goodchild AK : Baroreceptor reflex pathways and neurotransmitters: 10 years on. J Hypertens 2002; 20: 1675–1688.
Higuchi S, Takeshita A, Ito N, Imaizumi T, Matsuguchi H, Nakamura M : Arterial pressure and heart rate responses to calcium channel blockers administered in the brainstem in rats. Circ Res 1985; 57: 244–251.
Zanzinger J : Mechanisms of action of nitric oxide in the brain stem. Auton Neurosci 2002; 98: 24–27.
Patel KP, Li Y-F, Hirooka Y : Role of nitric oxide in central sympathetic outflow. Exp Biol Med 2001; 226: 814–824.
Hirooka Y, Sakai K, Kishi T, Ito K, Shimokawa H, Takeshita A : Enhanced depressor response to endothelial nitric oxide synthase gene transfer into the nucleus tractus solitarii of spontaneously hypertensive rats. Hypertens Res 2003; 26: 325–331.
Berkels R, Taubert D, Bartels H, Bretenbach T, Klaus W, Roesen R : Amlodipine increases endothelial nitric oxide by dual mechanisms. Pharmacology 2004; 70: 39–45.
Umemoto S, Tanaka M, Kawahara S, et al: Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats. Hypertens Res 2004; 27: 877–885.
Kerr S, Brosnan J, McIntyre M, Reid JL, Domniczak AF, Hamilton CA : Superoxide anion production is increased in a model of genetic hypertension. Hypertension 1999; 33: 1353–1358.
Kimoto-Kinoshita S, Nishida S, Tomura TT : Age-related change of anti-oxidant capacities in the cerebral cortex and hippocampus of stroke-prone spontaneously hypertensive rats. Neurosci Lett 1999; 273: 41–44.
Wilson SK : Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rat. Circ Res 1990; 66: 722–734.
Zhang XM, Ellis EF : Superoxide dismutase reduces permeability and edema induced by hypertension in rats. Am J Physiol 1990; 259: H497–H503.
Grunfeld S, Hamilton CA, Mesaros S, et al: Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 1995; 26: 854–857.
Spence JD : Preventing dementia by treating hypertension and preventing stroke. Hypertension 2004; 44: 20–21.
Furukawa T, Nukada T, Suzuki K, et al: Voltage and pH dependent block of cloned N-type Ca2+ channels by amlodipine. Br J Pharmacol 1997; 121: 1136–1140.
Uneyama H, Uchida H, Konda T, Yoshimoto R, Akaike N : Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca2+ channels. Eur J Pharmacol 1999; 373: 93–100.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hirooka, Y., Kimura, Y., Nozoe, M. et al. Amlodipine-Induced Reduction of Oxidative Stress in the Brain Is Associated with Sympatho-Inhibitory Effects in Stroke-Prone Spontaneously Hypertensive Rats. Hypertens Res 29, 49–56 (2006). https://doi.org/10.1291/hypres.29.49
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.29.49
Keywords
This article is cited by
-
Clarification of hypertension mechanisms provided by the research of central circulatory regulation
Hypertension Research (2023)
-
Manifestation of renin angiotensin system modulation in traumatic brain injury
Metabolic Brain Disease (2021)
-
Therapeutic Potential of Dihydropyridine Calcium Channel Blockers on Oxidative Injury Caused by Organophosphates in Cortex and Cerebellum: An In Vivo Study
Indian Journal of Clinical Biochemistry (2020)
-
Angiotensin II Causes Neuronal Damage in Stretch-Injured Neurons: Protective Effects of Losartan, an Angiotensin T1 Receptor Blocker
Molecular Neurobiology (2018)
-
Regulation of the sympathetic nervous system by nitric oxide and oxidative stress in the rostral ventrolateral medulla: 2012 Academic Conference Award from the Japanese Society of Hypertension
Hypertension Research (2013)